BGIM
RIGL icon

Brandywine Global Investment Management’s Rigel Pharmaceuticals RIGL Stock Holding History

Brandywine Global Investment Management’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$3.07M Sell
71,570
-2,600
-4% -$98K 0.02% 435
2025
Q3 		$2.1M Sell
74,170
-2,700
-4% -$80.8K 0.01% 475
2025
Q2 		$1.44M Buy
+76,870
New +$1.46M 0.01% 514
2022
Q2 		– Sell
-19,440
Closed -$581K – 765
2022
Q1 		$581K Hold
19,440
– – ﹤0.01% 651
2021
Q4 		$515K Sell
19,440
-6,372
-25% -$192K ﹤0.01% 615
2021
Q3 		$937K Buy
+25,812
New +$1.02M 0.01% 573

Other funds holding RIGL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Brandywine Global Investment Management's RIGL Position: Q4 2025 in Review

Brandywine Global Investment Management reduced its Rigel Pharmaceuticals (RIGL) stake by 3.5% in Q4 2025, selling an estimated $98K and leaving 71,570 shares worth $3.07M. The position accounts for 0.02% of the portfolio, ranked #435.

Brandywine Global Investment Management first reported a position in RIGL in Q3 2021 and has held it in 6 quarters since. 193 funds tracked by Wall St. Rank hold RIGL as of Q4 2025.

  • Brandywine Global Investment Management held 71,570 shares of Rigel Pharmaceuticals worth $3.07M as of Q4 2025.
  • Brandywine Global Investment Management sold 2,600 Rigel Pharmaceuticals shares in Q4 2025, an estimated $98K.
  • Rigel Pharmaceuticals made up 0.02% of Brandywine Global Investment Management's portfolio in Q4 2025, its #435 holding.
  • Brandywine Global Investment Management first reported a position in Rigel Pharmaceuticals in Q3 2021 and has held it in 6 quarters since.
  • 193 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2025.

Based on Brandywine Global Investment Management's 13F filing for Q4 2025, filed 11 Feb 2026.